ArticleAnatolian journal of cardiology2025

Effectiveness and Safety of Reduced-Dose and Slow-Infusion Intravenous Tissue-Type Plasminogen Activator Regimen in Patients with Acute Pulmonary Embolism at Intermediate-High Risk.

Barkın Kültürsay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.